study examines whether there is an independent relationship of isolated, nonspecific minor ST-T abnormalities to long-term risk of mortality due to myocardial infarction (MI), CHD, cardiovascular diseases (CVDs), and all causes, and evaluates whether frequency of occurrence of these abnormalities, as well as their severity and extent, in annual examinations for 5 years is associated with risk.
METHODS

Study Sample
Data are from the Chicago Western Electric Study initiated in the fall of 1957 as a long-term prospective investigation of CHD. Details of the selection of participants and their demographic characteristics have been reported. 24 Briefly, a group of 2107 middle-aged men employed by the Hawthorne Works of the Western Electric Company, Chicago, Ill, underwent an extensive baseline examination, including a 12-lead ECG at rest. For available survivors of this cohort, examinations including ECG were repeated annually for 11 subsequent years. This study used data from the first 5 examinations (ie, baseline and first 4 annual reexaminations). The decision to limit the baseline period to the first 5 annual examinations was made because (1) complete data on CVD risk factors were available for substantially more men for this period, and (2) this approach yielded a longer subsequent follow-up period.
Exclusions and Inclusions
Participants included in these analyses were men aged 40 to 55 years at baseline. Five men who were not in this age range, 43 men who had a history of CHD at entry, and 105 men who were diagnosed as having CHD during the 4 subsequent annual examinations were excluded. In addition, because the focus of these analyses was on isolated, minor ST-T abnormalities, 127 other men were excluded because they had 1 or more of the following major ECG abnormalities at baseline (n = 40) or at 1 or more of the 4 annual reexaminations (n = 87). These abnormalities may cause secondary ST-T change and affect prognosis: Q-QS wave . 25 Furthermore, 29 men who died prior to the fourth annual reexamination and 125 men who did not complete the 5 consecutive annual examinations were also excluded. The remaining 1673 men constitute the cohort of this study.
ECG Criteria
All ECGs were read according to the MC 25 at the University of Minnesota ECG reading center. Serial ECGs for the same person were coded and compared during the same coding period to ensure comparability of coding for serial tracings recorded in different years. All ECGs were coded without knowledge of clinical or demographic data.
Criteria for minor ST-segment depression were either of the following: (1) no ST-J depression as much as 0.5 mm but ST segment downward sloping and segment or T-wave nadir at least 0.5 mm below P-R baseline, in any of leads I, II, aVL, or V 2 to V 6 (MC, 4-3); or (2) ST-J depression of 1.0 mm or greater and ST segment upward sloping or U-shaped, in any of leads I, II, aVL, or V 1 to V 6 (MC, 4-4). Criteria for minor T-wave abnormality were either of the following: (1) T-wave amplitude zero (flat), negative, or diphasic (negative-positive type only) with less than 1.0 mm negative phase in lead I, II, V 3 to V 6 , or in lead aVL when R-wave amplitude is 5.0 mm or greater (MC, 5-3); or (2) T-wave amplitude positive and Tto R-wave amplitude ratio of less than 1:20 in any of leads I, II, aVL, or V 3 to V 6 when R-wave amplitude in the corresponding leads was 10.0 mm or greater (MC, 5-4). These definitions parallel those used in clinical practice.
Over the past 25 years, the reproducibility of ECG coding has been checked regularly in the Minneapolis ECG reading center (approximately every 3 months) on existing and surrogate ECG dossiers. The intercoder and intracoder reliability and k values for ST-wave patterns consistently are between 96% to 97% agreement (k, 0.82-0.86; SE, 0.03-0.06) and for T-wave patterns are 96% to 98% (k, 0.90-0.92; SE, 0.04-0.05). In the present study, ST-segment depression and T-wave abnormality were combined into 1 group of primary ST-T abn o r m a l i t i e s . T h e s e m i n o r S T -T abnormalities were then categorized according to frequency of appearance (recurrence) during 5 consecutive annual examinations into 4 groups: no abnormalities, 1 time only, 2 times only, and 3 or more times. In addition, the MCs were grouped according to severity of abnormality. The MC 4-4 and 5-4 were classified as less severe forms of abnormality, and MC 4-3 and 5-3 were considered more severe. Furthermore, extent of abnormality was assessed by counting the number of lead groups, ie, anterior (leads V 1 -V 5 ), anterolateral (I, aVL, V 6 ), and posterior (inferior) (II, III, aVF) in which the ST-T abnormality occurred.
Clinical Data and Follow-up
Other annual data collected and used in this study were age at baseline examination and average values from the first 5 examinations for body mass index (BMI) (weight in kilograms divided by height in meters squared), systolic and diastolic blood pressure (BP), serum total cholesterol, and cigarette smoking. Men continuing in the study were reexamined annually up to 1969. Vital status was subsequently determined by mailed questionnaires or telephone interviews through 25 years; data were available for all 2107 men. For year 33, data on vital status were obtained from the National Death Index, the Health Care Financing Administration, and surviving participants' responses to questionnaires; data were available for 2084 participants (98.9%). For analyses herein, follow-up began after the fifth examination and continued through the thirty-third anniversary of the initial examination.
Mortality End Points
Causes of death were classified by reviewing death certificates and were coded according to the International Classification of Diseases, Eighth Revision . 26 Coding was done independently in duplicate without knowledge of other information about participants. While the primary focus of this report is on associations of isolated nonspecific minor ST-T abnormalities with death due to MI (ICD-8 codes 410.0-410.9) and CHD (ICD-8 codes 410.0-414.9), results also are presented for CVDs (ICD-8 codes 400.0-445.9) and all causes of death.
Statistical Methods
Average values of characteristics at the first 5 annual examinations were calculated for groups of men defined based on frequency of minor ECG ST-T abnormalities: none, 1 time only, 2 times only, and 3 or more times, and compared using the Bonferroni method. Ageadjusted rates for mortality due to MI, all deaths due to CHD, all deaths due to CVDs, and deaths due to all causes were calculated per 10 000 person-years of follow-up for each group of men. Cox proportional hazards regression model 27 was used to estimate the relative risks (RRs) of death and 95% confidence intervals (CIs) for each group of men (compared with men without ST-T abnormalities) with adjustment for age, education, family history of heart disease, systolic BP, serum cholesterol level, cigarettes per day, BMI, and BMI squared, and to test for linear trend (for the 4 groups of minor ST-T abnormalities, classified as 0, 1, 2, and 3).
To evaluate the prognostic significance of severity and extent of these abnormalities, scores were computed by assigning 1 point to ST-T abnormalities coded as MC 4-4 or 5-4 (ie, less severe) and 2 points to those abnormalities coded as MC 4-3 or 5-3 (ie, more severe). Cumulative severity score (range, 0-10) for a man was computed by summing the scores across the 5 annual examinations. Cumulative extent score (range, 0-15) was calculated by summing the number of lead groups with any of these minor abnormalities in the 5 examinations. ), and was hypercholesterolemic. More than half were current smokers (54.8%), with a mean of 18 cigarettes smoked per day. On average, they had slightly less than a high school education and 19% had a family history of CVD. Age, BMI, serum total cholesterol levels, cigarette smoking, education, and family history of CVD did not differ significantly among the 4 groups. Systolic and diastolic BP were higher for those with minor ST-T abnormalities. Men with more frequent occurrence of ST-T abnormalities had higher percentage of a more severe form (ie, MC 4-3 or 5-3) and of abnormalities involving multiple lead groups.
RESULTS
Single and Recurrent Minor ST-T Abnormalities
Mortality and Minor ST-T Abnormalities
During 29 years of follow-up, there were 234 deaths due to MI, 352 deaths due to all CHD, 463 due to all CVDs, and 889 due to all causes (TABLE 3).
Higher age-adjusted rates of MI, CHD, CVDs, and mortality due to all causes were observed in men with 1 only, 2 only, and 3 or more minor ST-T abnormalities than men with none (Table 3) . There was a graded increase in 29-year mortality from those with normal ECG findings to those with ST-T abnormalities 1 time only, to those with abnormalities on multiple occasions (linear trend, PϽ.001). Men with 3 or more occurrences of ST-T abnormalities had 2 1 ⁄2 times the death rate due to MI, CHD, and all CVDs than men with normal ECG findings; they also had higher death rates due to all causes. Age-adjusted mortality rates for the 173 men with any recording of minor ST-T abnormalities (ie, Ն1 in 5 annual examinations) were higher for all end points compared with those with normal ECG findings throughout.
Two proportional hazards regression models were used to calculate RRs of mortality for the 4 groups of men with adjustment for: (1) age only, and (2) 
COMMENT
This prospective study demonstrates that in employed middle-aged men isolated, nonspecific minor ST-segment and/or T-wave abnormalities on repeat annual examinations were independently associated with increased risk of death due to MI, CHD, CVDs, and all causes. Risks were greater for men with only 2 and 3 or more occurrences of ST-T abnormalities than for men with abnormalities on only 1 occasion. Of clinical relevance for screening, compared with men with no abnormalities, men with 1 or more recordings of minor ST-T abnormalities in 5 years of annual examinations had an increased risk of 38% to 67% for cardiovascular, coronary, and MI death.
Our analysis focused on minor ST-T findings, which constitute a class of abnormalities generally considered less severe than the combined (minor and major) ST-T wave changes reported in most other studies. 2, 4, 11, 15 Ten percent of these middle-aged men, who were otherwise free of evidence of CHD, had minor ST-T abnormalities at least once in annual resting ECG examinations during 5 years. Other studies report similar rates of occurrence. Minor T-wave abnormality (MC, 5-3) was found in 12% of men aged 40 to 59 years in the community population in Tecumseh, Mich, 30 and in 9% of men of similar age in a religious sect living in the northwestern United States and southwestern Canada. 31 Kannel et al 12 reported that in Framingham Study examinations 8 to 12 (ie, over 4 years), 14.1% of men aged 44 to 74 years had nonspecific ECG abnormalities (STsegment depression Ն1 mm and/or Twave flattening or inversion). Thus, nonspecific ST-T abnormalities are common in apparently healthy people.
Consistent with the longstanding but unconfirmed impression of clinicians and epidemiologists, 12, 18, [21] [22] [23] the Western Electric data demonstrate that there was considerable intraindividual variation in frequency of occurrence of minor ST-T abnormalities over time. The ST-T abnormalities have been described in a number of situations besides the presence of organic heart disease, including with change in posture, 32 hyperventilation, 32 ingestion of food, 33 the hyperkinetic heart syndrome, 34 imbalance of the sympathetic nervous system, 34 or anxiety. 35 These factors, difficult to delineate and control, contribute to this variability. Hence, some authors believe that these abnormalities are the result of physiological influences and are not prognostically relevant. 23 It is also true that persons with confirmed CHD may manifest only transient asymptomatic ST-T changes. 36 One limitation of our study is that data on exercise were not available for inclusion in these analyses. Furthermore, information on use of medication and serum electrolytes were not collected. However, the likelihood is that the majority of participants were not taking medication that would affect ST-T waves (eg, digitalis) and that abnormal serum electrolyte levels were uncommon, given that the study cohort was a healthy working population and that participants with CHD or MI were excluded from these analyses.
Other possible noncardiac causes of variation are errors or differences in ECG recording technique and differences in interpretation across examinations. 37 The MC used in this study has been widely recommended for classification of ECGs for epidemiological purposes. 25 The principal advantage of this system is that all classifications are based on the semiquantitative magnitude of specific items, which should improve comparability between ECG readings taken on different occasions. In this study, all ECGs were coded at the same time in a serial, stan- dardized quality-controlled laboratory, which minimized intraobserver and interobserver variation. Therefore, it is likely that the large observed intraindividual variation in occurrence of minor ST-T abnormalities is not an artifact but a real feature of such abnormalities.
The predictive value of major ECG abnormalities for cardiovascular mortality has been well established. [4] [5] [6] [7] 9, 14, 38, 39 These ECG abnormalities include Q wave, [4] [5] [6] [7] 9 left ventricular hypertrophy, 9, 14, 38 and others (eg, atrial flutter and/or fibrillation, frequent ectopic ventricular beats, ventricular conduction defect, and complete left bundle branch block). 5, 7, 9 In the Western Electric cohort, the multivariateadjusted RRs of death due to CHD in 29 years for men with major abnormalities on their baseline ECG were: abnormal Q wave, 2.35 (95% CI, 1.41-3.90); left ventricular hypertrophy, 2.02 (95% CI, 1.01-4.26), and other major ECG abnormalities combined, 1.89 (95% CI, 1.03-3.47). The magnitudes of these risks were greater compared with that of any minor ST-T abnormalities described in this study (RR, 1.67; 95% CI, 1.25-2.25), indicating the relative importance of these abnormalities. However, for men with minor ST-T abnormalities on 3 or more of the ECGs during the first 5 years (RR, 2.39; 95% CI, 1.39-4.12), risk was similar to those for men with major abnormalities on the single baseline ECG.
The existing literature consistently shows an association of total or major prevalent ST-T abnormalities with a higher risk of death. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] Minor abnormalities, eg, ST-segment depression less than 0.5 mm (MC, 4-3), or junctional ST depression with upward-sloping (MC, 4-4), or decreased T-wave amplitude without inversion of 1.0 mm or more (MC, 5-3, 5-4), also have been examined in some studies, with inconsistent results, eg, reported as being of prognostic importance, 2, 4, 11, 18, 20 of some importance, 10, 17 and no prognostic significance. 19 Of particular concern, most investigations 2,4,10,11,17,18 did not isolate minor ST-T abnormalities from coexisting major ECG abnormalities, did not examine whether the relationship of these abnormalities to outcome was independent of other established coronary risk factors, and did not determine the meaning of occurrence of these abnormalities only 1 time vs more than once, in repeat examinations. Based on data from the Honolulu Heart Program, Knutsen et al 14 noted that individual ECG abnormalities frequently were correlated and that subsequent CHD rates were lower for each ECG category examined as an isolated abnormality, and some major ischemic ECG findings such as ST depression did not seem to indicate substantially increased risk when it was an isolated ECG finding in clinically diseasefree men.
In light of these concerns, our present analyses excluded persons with CHD or major ECG abnormalities, including major ST-segment (MC, 4-1 and 4-2), Twave (MC, 5-1 and 5-2) abnormality, or both, in the first 5 years. This ensured that the prognostic evaluation involved only isolated minor nonspecific ST-T abnormalities. No previous study has examined the predictive value of more than 1 occurrence of minor ST-T abnormalities on repeat annual examinations. Our data show that there was a significant trend of graded increase in RR from absence of abnormalities to serially recurring abnormalities. In addition, men with more frequent recurring abnormalities were also more likely to have the more severe codes (ie, MC, 4-3 and 5-3) and to have ST-T abnormalities in multiple lead groups. Both severity and extent apparently contribute to the higher mortality observed in persons with more frequent occurrence of minor ST-T abnormalities. Colinearity among these variables makes assessment of their separate impact on risks virtually impossible.
A great deal is now known about the frequency and prognosis of ECG abnormalities in patients with clinically overt heart disease. However, the practicing physician is often confronted with an ECG abnormality, such as minor ST-T change, as an incidental finding during a routine evaluation of an asymptomatic individual without a clinically apparent cardiac disorder. Our study implies that attention should be given to such an ECG finding as possibly clinically significant, worthy of diagnostic evaluation, and warranting interval ECG reexamination. Data from a careful history taking, physical examination, and laboratory assessment must be correlated with the ECG. It is also important to consider other major cardiovascular risk factors such as the patient's sex, age, population of origin, major modifiablepreventable traits (elevated BP, dyslipidemia, adverse dietary pattern, and cigarette smoking), and other lifestyle habits, because these may give meaning to the ECG finding. 4, 8, 13, 16 Although data from the Western Electric Study provide no direct evidence of the value of ECG screening for reducing cardiovascular risk, these data do provide evidence that minor isolated nonspecific ECG findings are prognostically important. Our findings suggest that recurrent nonspecific minor ST-T abnormalities on repeat examinations in middle-aged men indicate increased mortality risk and warrant especially vigorous preventive management against the occurrence of clinical CHD.
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